Opthea Ltd (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
OPT Nasdaq 8731 https://opthea.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Opthea Ltd (ADR)

Opthea to Present at the OIS Retina Innovation Summit at ARVO - Apr 25th, 2024 1:00 pm
Owning 39% shares,institutional owners seem interested in Opthea Limited (ASX:OPT), - Apr 12th, 2024 8:49 pm
Opthea Appoints John Han, PharmD, as VP Medical Affairs - Apr 8th, 2024 10:42 pm
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference - Apr 4th, 2024 10:34 pm
Opthea Appoints Sujal Shah to the Board of Directors - Apr 3rd, 2024 9:39 pm
7 Growth Stocks to Buy to Outperform the Nasdaq Index - Apr 3rd, 2024 1:53 pm
11 Best ASX Stocks To Buy Now - Mar 24th, 2024 11:55 am
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024 - Mar 19th, 2024 10:00 am
Opthea to Participate in the Leerink Partners Global Biopharma Conference - Mar 5th, 2024 10:08 pm
Opthea Reports Half-Year Financial Results and Business Updates - Feb 28th, 2024 10:55 pm
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor - Feb 19th, 2024 11:25 pm
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept - Feb 14th, 2024 12:00 pm
10 Best Australian Stocks To Buy - Feb 5th, 2024 8:11 am
Opthea Strengthens Team with Key Clinical and Regulatory Hires - Feb 1st, 2024 11:00 am
Opthea to Receive US$35M Commitment and Additional US$50M Funding - Dec 27th, 2023 11:00 am
Opthea Receives A$8.8 million R&D Tax Incentive - Dec 19th, 2023 11:00 am
Opthea to Present at the FLORetina 2023 Congress - Dec 1st, 2023 10:30 am
Opthea to Present at the Jefferies 2023 London Healthcare Conference - Nov 9th, 2023 10:30 am
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference - Oct 30th, 2023 9:30 am
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO - Oct 27th, 2023 9:30 am